Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CATX - Perspective Therapeutics Inc


Close
15.8
0.220   1.392%

Share volume: 949,353
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$15.58
0.22
1.41%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0.70%
1 Month
25.70%
3 Months
19.70%
6 Months
75.56%
1 Year
290.12%
2 Year
4,271.89%
Key data
Stock price
$15.80
P/E Ratio 
0.00
DAY RANGE
$15.54 - $16.13
EPS 
$0.00
52 WEEK RANGE
$2.05 - $19.05
52 WEEK CHANGE
$2.90
MARKET CAP 
1.065 B
YIELD 
N/A
SHARES OUTSTANDING 
67.428 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$789,249
AVERAGE 30 VOLUME 
$638,716
Company detail
CEO: Lori Woods
Region: US
Website: https://isoray.com/
Employees: 69
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

the introduction of cesium-131 represents the culmination of decades of work and millions of dollars of investment. top medical centers, hospitals and clinics across the united states are now offering this breakthrough treatment for cancer patients. the word brachytherapy derives from the greek prefix brachy, meaning “short” or “close,” because the titanium capsules containing the radioisotope are implanted directly into the cancerous prostate gland. treatment of cancer using low dose radiation or “seed” brachytherapy was pioneered in the 1960’s as an effective alternative to radical prostatectomy. pioneers in brachytherapy research initially theorized about the use of cesium-131 in a titanium capsule, however scientific and economic limitations at the time prevented its development and iodine-125 emerged as an alternative. beginning in 1967, iodine-125 became the first radioisotope manufactured in a titanium capsule, or seed. while its use continues to this day, many patients and doct

Recent news